|
Did you know as many as 92% of people use their asthma devices incorrectly? How you use your asthma inhaler can make a huge difference in how well your asthma is controlled. Our blog post talks about the different types of inhalers and how to use each one correctly to help you manage your asthma and feel better.
|
|
|
A type of severe asthma known as eosinophilic asthma may not respond to common asthma medicines. It may require a more specialized approach. Learn more about eosinophilic asthma, how it is treated, and how it can affect quality of life. |
|
|
June is almost over but there's still time to celebrate Healthy Home Month by taking our Healthier Home Assessment. Your home can have a big impact on how well you manage your asthma and allergies. Reducing asthma triggers and allergens in your home should be an important part of your asthma and allergy management plan. And CERTIFIED asthma & allergy friendly® products can help you do just that. Try out our healthier home tips now or any time of year.
|
|
|
AAFA President and CEO Joins White House Roundtable on Clean Air
On June 8, AAFA’s President and CEO, Kenneth Mendez, was invited by the White House to participate in a “Clean Air and Disability Justice” roundtable discussion held by the White House Office of Public Engagement and Office of Science and Technology Policy. Mendez discussed the profound health impacts indoor air quality (IAQ) has for the 25 million Americans with asthma, and the disparities that it perpetuates. He also stressed the negative health and learning impacts poor IAQ in schools has on children with asthma. Poor IAQ is a major factor triggering allergy and asthma symptoms and asthma is a leading cause of school absenteeism.
Schools, especially in systemically underfunded communities, need the resources and technical expertise to begin addressing IAQ in their buildings. To do so, Mendez expressed AAFA’s strong support for funding for the Environmental Protection Agency’s Office of Air and Radiation/Indoor Environments and it’s Office of Children’s Health Protection. AAFA will continue to advocate for children with asthma and looks forward to ongoing work with this Administration.
Today on June 30, the U.S. Supreme Court made a decision to restrict the EPA's authority to regulate emissions. AAFA urges the EPA to act quickly to use its full remaining authority to support cleaner air.
|
|
|
|
The FDA recently authorized both Moderna and Pfizer COVID-19 vaccines for children as young as 6 months old. Read the press release to learn more.
|
|
|
|
The FDA recently approved Dupixent® (dupilumab) as the first biologic treatment for children with moderate-to-severe atopic dermatitis. Learn more.
|
|
|
We’re partnering with the American Partnership for Eosinophilic Disorders (APFED) to learn more about the experiences of people living with eosinophilic esophagitis (EoE). You can help by participating in this research survey.
Your insights will help us guide educational content and programmatic resources around EoE. The survey should take less than 15 minutes to complete.
|
|
|
|
Are you impacted by nasal polyps? Some people who have asthma, allergic rhinitis, or chronic sinusitis may also have nasal polyps. During our recorded educational program, “Taking Charge to Breathe Easier: Strategies to Address Nasal Polyps,” you will learn how to take a more active approach to manage your nasal polyps and work with your doctor to improve treatment.
|
|
|
|
Are you a health care professional who treats someone with nasal polyps? The CME on-demand program for health care professionals, “Moving Toward a Targeted Approach for Nasal Polyps,” covers the patient burden of nasal polyps, limitations of traditional nasal polyp treatments, rationale for targeted approaches for nasal polyp management, and more. Watch the session for health care professionals on demand.
|
|
|
Everything AAFA does is in service of helping people with asthma and allergies, their families, and their communities. We understand that an asthma or allergy diagnosis can be a life‐changing event. For those affected, we stand together, prepared not only to listen and empathize, but also to serve as a lifeline of support and a reliable helpmate for life.
AAFA elevates and amplifies the voice of the patient. When we meet with Congress, the FDA, the CDC, researchers, physicians, schools, health departments, manufacturers, or other stakeholders, we put patients and their families at the center. We educate, advocate, and demand better for people with asthma and allergies.
AAFA is dedicated to saving lives and reducing the burden of disease for people with asthma and allergies through support, advocacy, education, and research. Through a gift to AAFA, you help us continue to provide life-saving programs and life-changing improvements to treatments and policies to help families for years to come.
|
|
|
Check out our previous issues to learn about honey and pollen allergies, SMART asthma treatment method for children, benefits of air cleaners, and more.
|
|
|
|
|
